Safety and Pharmacokinetics of Subcutaneous Blinatumomab (SC blinatumomab) for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL); Results from a Phase 1b Study

Blood（2022）

引用 8|浏览15

暂无评分

摘要

Background

查看译文

关键词

subcutaneous blinatumomab,sc blinatumomab,lymphoblastic leukemia,pharmacokinetics,b-all

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要